단백질 치료제 개발에 대한 관심 증가, 재조합 단백질 약물의 지속적인 혁신, 항체 기반 약물의 성장으로 인해 다음과 같은 연구가 증가했습니다. 단백질 공학. 치료용 단백질과 펩타이드는 암, 신경퇴행성 질환 등 다양한 질병의 치료에 큰 잠재력이 있는 것으로 확인되었습니다. 그러나 단백질의 물리화학적 불안정성과 면역원성 문제는 예측 기간 동안 전 세계 단백질 치료제 시장을 억제할 가능성이 높습니다.
"2031년까지의 글로벌 단백질 치료제 시장 분석"은 다음과 같은 전문적이고 심층적인 연구입니다. 글로벌 시장 동향에 주목하는 생명공학 산업. 이 보고서는 제품, 애플리케이션, 최종 사용자 및 지역별로 상세한 시장 세분화를 통해 글로벌 시장에 대한 개요를 제공하는 것을 목표로 합니다. 글로벌 단백질 치료제 시장은 예측 기간 동안 높은 성장을 보일 것으로 예상됩니다. 이 보고서는 주요 단백질 치료제 시장 참가자의 시장 상태에 대한 주요 통계를 제공하고 시장의 주요 추세와 기회를 제공합니다.
글로벌 단백질 치료제 시장은 제품, 응용 프로그램, 최종 제품을 기준으로 분류됩니다. 사용자. 제품을 기준으로 시장은 단클론 항체, 인슐린, 융합 단백질, 에리스로포이에틴, 인터페론, 인간 성장 호르몬 및 난포 자극 호르몬으로 분류됩니다. 단백질 치료제 시장은 용도별로 크게 대사질환, 면역질환, 혈액질환, 암, 호르몬질환, 유전질환 등으로 분류된다. 최종 사용자를 기준으로 단백질 치료제 시장은 제약 회사, 의료 서비스 제공자, 연구 기관 및 기타 분야로 분류됩니다. 학술 연구 기관.
이 보고서는 정성적, 정량적 정보를 모두 포함하여 업계에 대한 자세한 개요를 제공합니다. 이는 글로벌 단백질 치료제 시장 기반 제품, 애플리케이션 및 최종 사용자에 대한 개요 및 예측을 제공합니다. 또한 5개 주요 지역과 관련된 전체 시장에 대해 2031년까지 시장 규모와 예측을 제공합니다. 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남부 & 중앙 아메리카. 각 지역별 단백질 치료제 시장은 나중에 각 국가 및 부문별로 세분화됩니다. 이 보고서는 전 세계 13개국에 대한 분석 및 예측과 함께 이 지역에 만연한 현재 추세 및 기회를 다루고 있습니다.
북미는 2021년 단백질 치료제 시장에서 지배적인 점유율을 차지했습니다. 주요 점유율은 기술 발전에 기인합니다. , 우호적인 급여정책, 신제품 개발, 생활수준 향상 등으로 인해 기대수명이 연장되어 노인인구 증가에 기여하고 있습니다. 이러한 요인들은 이 지역에서 단백질 치료제의 성장을 촉진하고 있습니다.
아시아 태평양 지역은 당뇨병과 같은 만성 질환의 유병률이 높기 때문에 예측 기간 동안 가장 높은 CAGR을 보일 것으로 예상됩니다. 또한 아시아 태평양 지역의 의료 관광 산업 성장은 예측 기간 동안 단백질 치료제 시장에 대한 시장 수요를 촉진할 것으로 예상되는 주요 요인이기도 합니다. 또한 고급 치료 옵션에 대한 수요 증가, 중국, 인도, 일본과 같은 신흥 경제, 1인당 소득 증가와 같은 요인은 예측 기간 동안 아시아 태평양 시장 플레이어에게 성장 수단을 창출할 것으로 예상됩니다.
이 보고서는 수요와 공급 측면 모두에서 단백질 치료제 시장에 영향을 미치는 요인을 분석하고 예측 기간 동안 시장에 영향을 미치는 시장 역학, 즉 동인, 제약, 기회 및 미래 추세를 추가로 평가합니다. 이 보고서는 또한 5개 지역 모두에 대한 철저한 PEST 분석을 제공합니다. 북미, 유럽, APAC, MEA 및 남부 & 중앙 아메리카는 이 지역의 단백질 치료제 시장에 영향을 미치는 정치적, 경제적, 사회적 및 기술적 요인을 평가한 후입니다.
이 보고서에는 SWOT 분석 및 시장 전략과 함께 주요 단백질 치료제 회사의 프로필도 포함되어 있습니다. 또한 이 보고서는 회사 프로필, 제공된 구성 요소 및 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 개발과 같은 정보를 제공하는 업계 선두 기업에 중점을 둡니다. 단백질 치료제 시장의 주요 기업으로는 Novo Nordisk A/S, Janssen Global Services, LLC(Johnson & Johnson Services, Inc.), Amgen Inc., AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries 등이 있습니다. Ltd., Kyowa Hakko Kirin Co., Ltd., Pfizer Inc., F. Hoffmann-La Roche Ltd. 등이 있습니다.
.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Key companies in this market are - Novo Nordisk A/S, Janssen Global Services LLC, Johnson & Johnson Services Inc, Amgen Inc, AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Kyowa Hakko Kirin Co Ltd, Pfizer Inc
The Protein Therapeutics Market is expected to witness a shift towards personalised medicine with enormous focus on tailored therapy. Innovative therapeutic proteins, better drug design and advancement in protein engineering would deliver enhanced efficacy, addressing specific patient need and expanding market applications.
The market is expected to register a CAGR of 6.5% during 2023-2031
Fueling the growth of the Protein Therapeutics Market is the rising incidence of chronic diseases, and the growing need for biologic therapeutics. Also, the rising demand for protein-based therapies is due to the rising acceptance of biological therapies, global efforts to cure chronic diseases, and scientific advancements in protein engineering and manufacturing.
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Novo Nordisk A/S
2. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
3. Amgen Inc.
4. AstraZeneca
5. Baxter
6. Boehringer Ingelheim International GmbH
7. Teva Pharmaceutical Industries Ltd.
8. Kyowa Hakko Kirin Co., Ltd.
9. Pfizer Inc.
10. F. Hoffmann-La Roche Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.